iDegs inhibited tumor growth in SKOV‐3 tumor‐bearing mice and led to prolonged survival, demonstrating efficacy in in vivo, which promises to inspire novel medicinal chemistry programs aimed at IDO1 in different diseases. Here, IDO1 is linked to neoplasm.